Shanghai Pharmaceutical Holdings Co. financial statements, including revenue, expenses, profit, and loss

The total revenue of S1R for the last quarter is 9.01 B EUR, and it's 14.78% higher compared to the previous quarter. The net income of Q1 24 is 198.66 M EUR.